🔴 CLRO is trading 8.4% down today on profit-taking after brain-implant merger surge

CLRO is trading 8.4% down at $6.41 as the stock faces a pullback following a massive speculative rally driven by its recent merger announcement.

• The stock surged over 100% late last week after announcing a reverse merger with brain-implant company Cortigent.
• Investors are likely taking profits as the company prepares for a planned $10–15 million capital raise.
• The current decline reflects high volatility following the sharp two-day advance on the merger news.